Patient Leaflet Updated 10-May-2023 | SANOFI
Rilutek 50 mg film-coated tablets
RILUTEK® 50 mg film-coated tablets
Riluzole
Is this leaflet hard to see or read?
Phone 0800 035 2525 for help.
1. What RILUTEK is and what it is used for
2. What you need to know before you take RILUTEK
3. How to take RILUTEK
4. Possible side effects
5. How to store RILUTEK
6. Contents of the pack and other information
The active substance in RILUTEK is riluzole which acts on the nervous system.
RILUTEK is used in patients with amyotrophic lateral sclerosis (ALS).
ALS is a form of motor neurone disease where attacks of the nerve cells responsible for sending instructions to the muscles lead to weakness, muscle waste and paralysis.
The destruction of nerve cells in motor neurone disease may be caused by too much glutamate (a chemical messenger) in the brain and spinal cord. RILUTEK stops the release of glutamate and this may help in preventing the nerve cells being damaged.
Please consult your doctor for more information about ALS and the reason why this medicine has been prescribed for you.
Talk to your doctor before taking RILUTEK:
If any of the above applies to you, or if you are not sure, tell your doctor who will decide what to do.
If you are less than 18 years of age, the use of RILUTEK is not recommended because there is no information available in this population.
Tell your doctor if you are taking, have recently taken or might take any other medicines.
You MUST NOT take RILUTEK if you are or think you may be pregnant, or if you are breast-feeding.
If you think you may be pregnant, or if you intend to breast-feed, ask your doctor for advice before taking RILUTEK.
You can drive or use any tools or machines, unless you feel dizzy or light-headed after taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially “sodium free”.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
If you take too many tablets, contact your doctor or the nearest hospital emergency department immediately.
If you forget to take your tablet, leave out that dose completely and take the next tablet at the usual time. Do not take a double dose to make up for a forgotten tablet.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor immediately
Very common side effects (may affect more than 1 in 10 people) of RILUTEK are:
Common side effects (may affect up to 1 in 10 people) of RILUTEK are:
Uncommon side effects (may affect up to 1 in 100 people) of RILUTEK are:
Not known: frequency cannot be estimated from the available data
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
United Kingdom
You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
The tablets are film-coated, capsule-shaped and white. Each tablet contains 50 mg of riluzole and is engraved with “RPR 202” on one side.
RILUTEK is available in a pack of 56 tablets to be taken orally.
Market Authorisation Holder
Manufacturer
This leaflet was last revised in 11/2022
This leaflet does not contain all the information about your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist.
R400047
Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
+44 (0)800 035 2525